Thermometry
AlfaThermometry is a unique system that offers a view of a client’s whole-body health and hidden ailments. It’s a diagnostic device that utilizes state-of-the-art technology and artificial intelligence. This technology was utilized in Germany, implemented by Dr. Schwamm of Munich in 1980. Drs. Petra Blum and Reimar Banis taught the method to Dr. Daniel Beilin in 2001, and Dr. Beilin brought the first model through the FDA in 2002. In 2013 Dr, Beilin designed the new infrared probe with engineers and brought the improved version, the AlfaSight, through the FDA once more.
Thermometry can detect physiological changes up to 5 years in advance of an identifiable disease preceding cellular damage or dysfunction. Scans are safe and can be performed as often as necessary. Your practitioner can monitor treatment plans by repeatedly measuring the benefits of various healing strategies and applications. Tissue chemistry and metabolism can be measured to identify the vulnerabilities to various disorders. By understanding origins and causations of disease, your provider can provide you with prophylactic and effective care and treatment. Although AlfaSight is not diagnostic, it does provide information that often leads to the correct test such as MRI or laboratory test that determines the diagnosis. Alfa provides an adjunct to diagnosis, but a very educated and well-directed, reproducible test based on dynamic physiology and neurological connections. The list of indications it can detect include neoplastic and inflammatory conditions, abnormal conditions of the female breast, thyroid disorders, musculoskeletal disorders, and cerebrovascular disorders.